A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo as induction therapy in participants with moderately and severely active Crohn\'s disease (CD).
Epistemonikos ID: ca90c4c6443ec4b38ff2c0f09ad774e85b6a0de3
First added on: Jul 25, 2023